Month: January 2024

Med henvisning til meddelelse af 8. januar 2024 offentliggøres finanstilsynsgodkendte vedtægter, hvoraf det fremgår, at afdelingen SEB Japan Aktier SRI AKL er under afvikling.  Vedtægterne er vedhæftet.  Såfremt der måtte være spørgsmål til denne meddelelse, kan direktør Lise Bøgelund Jensen kontaktes på 3328 2828. Med venlig hilsen Investeringsforeningen SEBinvestAttachment2024 01 08 Vedtægter SEBinvest

Panevezio statybos trestas AB (PST) hereby informs that on 23 January 2024 PST, its former managing director D. Gesevičius and insurers R&Q Syndicate Management Limited and Marco International Insurance Company Limited entered into a settlement arrangement, in accordance with which all court and arbitration proceedings regarding the civil liability of the former managing director D. Gesevičius and the related insurance payouts (all in connection with the fine imposed by the Competition Council of the Republic of Lithuania on 20 December 2017 (No. 2S-11 (2017)) shall be amicably discontinued. Pursuant to the executed settlement agreements, the insurers will pay PST EUR 1,200,000, and PST will waive (withdraw) all its claims against the insurers and the former managing director D. Gesevičius. More information:Tomas StukasManaging DirectorTel.:...

Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcareMr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built and ultimately managed the sale of the company for $1.53 billionIRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to serve as the Chairman of the Board of Directors of Biomerica. Mr. Zack Irani will continue to serve as CEO. Mr. Kenny joined the Biomerica Board of Directors in August 2023 as an independent director. Most recently Mr. Kenny served as the CEO and executive board member at Meridian Biosciences (formerly...

1-for-21 reverse stock split to become effective as of the opening of trading on Thursday, January 25, 2024 GRANT–VALKARIA, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) — Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival Brands,” or the “Company”), today announced that it is effecting a 1-for-21 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock (the “Common Stock”), effective with the opening of trading on Thursday, January 25, 2024. Kaival Brands’ Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “KAVL”. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 483104402. The Reverse Stock Split was approved by the Board of Directors of the Company (the “Board”) and Kaival Holdings, LLC, a Delaware limited liability...

First Merchants Bank Announces Plans to Expand in Detroit, Bringing Financial Services to FitzgeraldFirst Merchants Bank Announces Plans to Expand in Detroit, Bringing Financial Services to FitzgeraldMUNCIE, Ind., Jan. 23, 2024 (GLOBE NEWSWIRE) — First Merchants Bank of Muncie, a leading community bank committed to serving the needs of all, announced today the plans for its newest branch in the Fitzgerald neighborhood, located at 7525 West McNichols Road. The new branch will provide residents convenient access to essential banking products and services, including checking and savings accounts, loans, online banking, and a local and invested team to help people prosper. “We are excited to open our doors in Fitzgerald and become a part of this vibrant community,” said Artina Packnett, Banking Center Manager for the new Fitzgerald...

ANDOVER, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release fourth quarter and full year 2023 financial results after market close on Wednesday, February 7, 2024. A conference call with management will be held on Thursday, February 8, 2024 at 8:30 a.m. (Eastern Time). A live and archived webcast of the call will be available on the company’s website at https://investor.mks.com/. To participate in the call by phone, participants should register online by clicking here, where dial in details will be provided. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. About MKS Instruments MKS Instruments...

REDWOOD CITY, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has awarded the innovative medicine designation, the Innovation Passport, to RZ358 for the treatment of hypoglycemia due to congenital hyperinsulinism (HI). The Innovation Passport designation was granted based on the substantial unmet medical need in this condition and the potential for RZ358 to benefit patients as evidenced by the Phase 2 RIZE study in congenital HI, which safely demonstrated significant improvements in hypoglycemia events. The Innovation Passport designation in the U.K. is the entry point to the Innovative...